Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
12(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
25%
Ph phase_3
1
4%
Ph early_phase_1
1
4%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

12

trials recruiting

Total Trials

24

all time

Status Distribution
Active(13)
Completed(6)
Terminated(2)
Other(3)

Detailed Status

Recruiting10
Completed6
unknown3
Withdrawn2
Active, not recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
12
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (12.5%)
Phase 31 (12.5%)
N/A6 (75.0%)

Trials by Status

not_yet_recruiting14%
withdrawn28%
recruiting1042%
unknown313%
active_not_recruiting28%
completed625%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT07243262

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

Recruiting
NCT05727020

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

Recruiting
NCT06408220Not Applicable

Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer

Recruiting
NCT07260734

AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)

Not Yet Recruiting
NCT05973656Not Applicable

Role of Acetaldehyde in the Development of Oral Cancer

Recruiting
NCT07038785

Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs

Recruiting
NCT04827368

Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease

Active Not Recruiting
NCT05844514

COlorectal BReath Analysis (COBRA2)

Recruiting
NCT06342752

The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)

Recruiting
NCT06611293

HOspital Versus Primary Care Breath Test Environment (HOPE) Study

Recruiting
NCT06764641

PAN Alimentary Cancer Exhaled Breath Analysis

Recruiting
NCT06302660

Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors

Active Not Recruiting
NCT06285734

Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention

Recruiting
NCT06022588Not Applicable

Chronic Mesenteric Ischemia Breath Testing

Completed
NCT04001478

Non-invasive Testing for Early oEesophageal Cancer and Dysplasia

Unknown
NCT01840150Not Applicable

Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer

Completed
NCT04760639

COVID Breath Test - Ancon

Completed
NCT04419207

Detecting Lung Cancer Based on Exhaled Breath

Completed
NCT04329507

Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS)

Completed
NCT03451994

Exploratory Study of Volatile Organic Compounds in Alveolar Breath

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
24